Global Endometriosis Therapies Market Research Report 2012-2024
Table of Contents
1 Market Overview
- 1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
- 1.2 Market Segment
- 1.2.1 by Type
- 1.2.1.1 Hormonal Contraceptives
- 1.2.1.2 Gonadotropin-releasing Hormone (Gn-RH) Agonists
- 1.2.1.3 Progestin Therapy
- 1.2.1.4 Aromatase Inhibitors
- 1.2.2 by Application
- 1.2.2.1 Hospital
- 1.2.2.2 Clinic
- 1.2.2.3 Other
- 1.2.3 by Regions
- 1.2.1 by Type
2 Industry Chain
- 2.1 Industry Chain Structure
- 2.2 Upstream
- 2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics
3 Environmental Analysis
- 3.1 Policy
- 3.2 Economic
- 3.3 Technology
- 3.4 Market Entry
4 Market Segmentation by Type
- 4.1 Market Size
- 4.1.1 Hormonal Contraceptives Market, 2013-2018
- 4.1.2 Gonadotropin-releasing Hormone (Gn-RH) Agonists Market, 2013-2018
- 4.1.3 Progestin Therapy Market, 2013-2018
- 4.1.4 Aromatase Inhibitors Market, 2013-2018
- 4.2 Market Forecast
- 4.2.1 Hormonal Contraceptives Market Forecast, 2019-2024
- 4.2.2 Gonadotropin-releasing Hormone (Gn-RH) Agonists Market Forecast, 2019-2024
- 4.2.3 Progestin Therapy Market Forecast, 2019-2024
- 4.2.4 Aromatase Inhibitors Market Forecast, 2019-2024
5 Market Segmentation by Application
- 5.1 Market Size
- 5.1.1 Hospital Market, 2013-2018
- 5.1.2 Clinic Market, 2013-2018
- 5.1.3 Other Market, 2013-2018
- 5.2 Market Forecast
- 5.2.1 Hospital Market Forecast, 2019-2024
- 5.2.2 Clinic Market Forecast, 2019-2024
- 5.2.3 Other Market Forecast, 2019-2024
6 Market Segmentation by Region
- 6.1 Market Size
- 6.1.1 Asia-Pacific
- 6.1.1.1 Asia-Pacific Market, 2012-2018
- 6.1.1.2 Asia-Pacific Market by Type
- 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
- 6.1.2.1 North America Market, 2012-2018
- 6.1.2.2 North America Market by Type
- 6.1.2.3 North America Market by Application
- 6.1.3 Europe
- 6.1.3.1 Europe Market, 2012-2018
- 6.1.3.2 Europe Market by Type
- 6.1.3.3 Europe Market by Application
- 6.1.4 South America
- 6.1.4.1 South America Market, 2012-2018
- 6.1.4.2 South America Market by Type
- 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
- 6.1.5.1 Middle East & Africa Market, 2012-2018
- 6.1.5.2 Middle East & Africa Market by Type
- 6.1.5.3 Middle East & Africa Market by Application
- 6.1.1 Asia-Pacific
- 6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
- 7.1 Global Market by Vendors
- 7.2 Market Concentration
- 7.3 Price & Factors
- 7.4 Marketing Channel
8 Major Vendors
- 8.1 AbbVie
- 8.2 Eli Lilly
- 8.3 AstraZeneca
- 8.4 Bayer
- 8.5 Astellas Pharma
- 8.6 Meditrina Pharmaceuticals
- 8.7 Pfizer
- 8.8 Neurocrine Biosciences
- 8.9 Takeda Pharmaceutical
9 Conclusion
Summary
The global Endometriosis Therapies market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Hormonal Contraceptives
Gonadotropin-releasing Hormone (Gn-RH) Agonists
Progestin Therapy
Aromatase Inhibitors
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Clinic
Other
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa